Liquidation: JPMorgan Trust I

Form Type: 497

Filing Date: 2025-07-01

Corporate Action: Liquidation

Type: New

Accession Number: 000119312525152934

Filing Summary: JPMorgan Trust I has announced the liquidation and dissolution of the JPMorgan Total Return Fund, effective on or about July 29, 2025. This decision was approved by the Board of Trustees on May 12, 2025. As a consequence, the Fund will modify its investment strategies to increase cash holdings in preparation for liquidation. Shareholders will receive a pro-rata distribution of the Fund's assets on the Liquidation Date, subject to certain conditions regarding unpaid liabilities. Income and capital gain distributions may occur prior to the Liquidation Date. Additionally, certain fee waivers for investment advisory expenses will be in effect through the liquidation process. Shares in Fund direct IRA accounts will be exchanged for Morgan Shares of the JPMorgan U.S. Government Money Market Fund unless otherwise instructed by account holders. Investors are informed of deadlines for new purchases and additional shares as liquidation progresses.

Form Type: 497K

Filing Date: 2025-07-01

Corporate Action: Liquidation

Type: Update

Accession Number: 000119312525152935

Filing Summary: JPMorgan Trust I has announced the liquidation and dissolution of the JPMorgan Total Return Fund, effective July 29, 2025. This decision was made by the Board of Trustees on May 12, 2025. The Fund will adjust its investment strategy to increase cash holdings in preparation for liquidation. On the Liquidation Date, assets will be distributed pro rata to shareholders of record, except for proceeds from non-liquidatable securities, necessary cash for liabilities, and potential contingencies. Income dividends and capital gains, if any, may be distributed before the Liquidation Date. Distribution Fees on Fund shares will be waived starting June 1, 2025. The adviser has agreed to waive certain fees if Total Annual Fund Operating Expenses exceed specified limits. IRA account shares will be exchanged for Morgan Shares of the JPMorgan U.S. Government Money Market Fund, with alternative investment options available for other IRA accounts. Shareholders can purchase other J.P. Morgan Funds with liquidation proceeds under certain conditions. New purchases from new shareholders will be discontinued from May 19, 2025, and additional purchases from existing shareholders will be halted after July 22, 2025, with exceptions for certain plans.

Form Type: 497K

Filing Date: 2025-07-01

Corporate Action: Liquidation

Type: Update

Accession Number: 000119312525152937

Filing Summary: The document announces the liquidation and dissolution of the JPMorgan Total Return Fund, a series of JPMorgan Trust I, approved by the Board of Trustees on May 12, 2025, with an effective liquidation date set for July 29, 2025. In preparation for the liquidation, the Fund is adjusting its investment strategies to increase cash holdings. Proceeds from the liquidation will be distributed pro rata to shareholders of record, covering all assets except for unreleased securities and necessary cash to settle unpaid liabilities. Notably, distribution fees on Fund shares will be waived starting June 1, 2025, and total annual operating expenses will be controlled to not exceed specified limits. Shareholders will have options to exchange their shares for Morgan Shares of another money market fund unless alternative arrangements are made prior to the Liquidation Date. Furthermore, once liquidation occurs, shareholders can reinvest their proceeds into other J.P. Morgan Funds without penalties within a specified period. New and additional share purchases will be restricted prior to key dates leading up to liquidation, underscoring the urgency for interested investors to act accordingly.

Form Type: DEFA14A

Filing Date: 2025-06-18

Corporate Action: Liquidation

Type: New

Accession Number: 000119312525142647

Filing Summary: JPMorgan Trust I is presenting a proposal to its shareholders regarding the liquidation of its fund. The plan involves transferring all assets and liabilities of the fund to the JPMorgan Municipal ETF (the 'Acquiring Fund') in exchange for shares of the Acquiring Fund, with the aggregate net asset value (NAV) being equivalent to the total NAV of the fund. Following this transfer, the fund will distribute the corresponding portion of shares of the Acquiring Fund to its shareholders, which may include cash in lieu of fractional shares. This resolution will be addressed during a special meeting scheduled for July 30, 2025, and shareholders are encouraged to provide their voting instructions by July 29, 2025, to ensure their votes are counted. The document serves as a voting instruction form for registered shareholders, encouraging their participation in the upcoming meeting and to adopt the proposed agreement and plan of reorganization.

Form Type: 497

Filing Date: 2025-05-12

Corporate Action: Liquidation

Type: New

Accession Number: 000119312525117329

Filing Summary: The Board of Trustees of JPMorgan Trust I has approved the liquidation and dissolution of the JPMorgan Total Return Fund on or about July 29, 2025. In preparation for the liquidation, the Fund will modify its investment strategies to increase cash holdings. On the Liquidation Date, the Fund will distribute all assets to shareholders of record in cancellation of their shares, retaining an estimated amount to cover unpaid liabilities. Income dividends and capital gains may be paid before the Liquidation Date. Fund expenses will be waived through liquidation, with specific limits for different share classes. Shareholders will have options for transferring proceeds to other J.P. Morgan Funds, with specific terms about eligibility and fees. Purchases of new shares will be halted on May 19, 2025, and existing shareholders will not be able to buy additional shares after July 22, 2025, unless under certain reinvestment plans.

Form Type: 497K

Filing Date: 2025-05-12

Corporate Action: Liquidation

Type: New

Accession Number: 000119312525117330

Filing Summary: The Board of Trustees of JPMorgan Trust I has approved the liquidation and dissolution of the JPMorgan Total Return Fund on or about July 29, 2025. This decision allows the Fund to depart from its stated investment objective and strategies to increase cash holdings in preparation for liquidation. On the Liquidation Date, the Fund will distribute all assets to its shareholders, subject to retaining enough cash to cover unpaid liabilities. Income dividends and capital gain distributions may be paid prior to the Liquidation Date. Effective June 1, 2025, the Distribution Fees on Fund shares will be waived, and the Fund's adviser and affiliates will voluntarily waive fees exceeding specific percentages for various Classes of Shares. Shareholders will have options for reinvestment into other J.P. Morgan Funds with proceeds from the liquidation, including waivers for certain classes within 90 days of the liquidation. New purchases of Fund shares will be suspended after May 19, 2025, and additional purchases after July 22, 2025, will be restricted, except for specific plans.

Form Type: 497K

Filing Date: 2025-05-12

Corporate Action: Liquidation

Type: Update

Accession Number: 000119312525117331

Filing Summary: The Board of Trustees of JPMorgan Trust I has approved the liquidation and dissolution of the JPMorgan Total Return Fund, scheduled for around July 29, 2025. In preparation for this, the Fund will start increasing cash holdings and may depart from its stated investment objectives. On the Liquidation Date, all assets will be distributed pro rata to shareholders, barring any securities that cannot be liquidated, reserve cash for liabilities, and other obligations through the Liquidation Date. Income dividends and capital gains distributions may be paid before the Liquidation Date. Distribution fees on shares will be waived starting June 1, 2025. Shareholders will have various options for handling their investments post-liquidation, including exchanging for Morgan Shares or purchasing other J.P. Morgan Fund classes with proceeds. New share purchases will be halted after May 19, 2025, and additional purchases from existing shareholders will cease on July 22, 2025, with exceptions for certain plans. Investors are advised to retain this supplement with related documents for reference.